[PHARMA] YoY Quarter Result on 30-Sep-2015 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
26-Nov-2015
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2015
Quarter
30-Sep-2015 [#3]
Profit Trend
QoQ- 23.15%
YoY- 33.54%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Quarter Result
30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 CAGR
Revenue 587,660 574,503 515,215 524,413 502,086 440,807 426,460 5.48%
PBT 17,603 15,271 19,923 25,337 24,945 13,461 28,493 -7.70%
Tax -2,298 -11,381 -7,275 -5,362 -9,944 -9,291 -2,957 -4.11%
NP 15,305 3,890 12,648 19,975 15,001 4,170 25,536 -8.17%
-
NP to SH 15,051 3,580 13,061 19,971 14,955 3,751 25,247 -8.25%
-
Tax Rate 13.05% 74.53% 36.52% 21.16% 39.86% 69.02% 10.38% -
Total Cost 572,355 570,613 502,567 504,438 487,085 436,637 400,924 6.10%
-
Net Worth 522,618 531,892 531,250 534,373 507,124 473,402 496,469 0.85%
Dividend
30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 CAGR
Div 13,000 12,973 10,365 23,312 20,698 7,760 11,764 1.67%
Div Payout % 86.38% 362.37% 79.37% 116.73% 138.41% 206.90% 46.60% -
Equity
30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 CAGR
Net Worth 522,618 531,892 531,250 534,373 507,124 473,402 496,469 0.85%
NOSH 260,505 259,821 259,146 259,027 258,737 258,689 117,646 14.15%
Ratio Analysis
30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 CAGR
NP Margin 2.60% 0.68% 2.45% 3.81% 2.99% 0.95% 5.99% -
ROE 2.88% 0.67% 2.46% 3.74% 2.95% 0.79% 5.09% -
Per Share
30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 CAGR
RPS 226.02 221.42 198.81 202.45 194.05 170.40 362.49 -7.56%
EPS 5.79 1.38 5.04 7.71 5.78 1.45 21.46 -19.60%
DPS 5.00 5.00 4.00 9.00 8.00 3.00 10.00 -10.90%
NAPS 2.01 2.05 2.05 2.063 1.96 1.83 4.22 -11.62%
Adjusted Per Share Value based on latest NOSH - 259,027
30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 CAGR
RPS 40.77 39.86 35.75 36.39 34.84 30.58 29.59 5.48%
EPS 1.04 0.25 0.91 1.39 1.04 0.26 1.75 -8.30%
DPS 0.90 0.90 0.72 1.62 1.44 0.54 0.82 1.56%
NAPS 0.3626 0.369 0.3686 0.3708 0.3519 0.3285 0.3445 0.85%
Price Multiplier on Financial Quarter End Date
30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 CAGR
Date 28/09/18 29/09/17 30/09/16 30/09/15 30/09/14 30/09/13 28/09/12 -
Price 2.89 4.14 5.58 6.50 4.63 4.82 7.55 -
P/RPS 1.28 1.87 2.81 3.21 2.39 2.83 2.08 -7.76%
P/EPS 49.93 300.05 110.71 84.31 80.10 332.41 35.18 6.00%
EY 2.00 0.33 0.90 1.19 1.25 0.30 2.84 -5.67%
DY 1.73 1.21 0.72 1.38 1.73 0.62 1.32 4.60%
P/NAPS 1.44 2.02 2.72 3.15 2.36 2.63 1.79 -3.55%
Price Multiplier on Announcement Date
30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 CAGR
Date 19/11/18 15/11/17 21/11/16 26/11/15 21/11/14 19/11/13 06/11/12 -
Price 3.09 3.82 5.70 6.50 4.45 4.72 8.25 -
P/RPS 1.37 1.73 2.87 3.21 2.29 2.77 2.28 -8.13%
P/EPS 53.38 276.85 113.10 84.31 76.99 325.52 38.44 5.62%
EY 1.87 0.36 0.88 1.19 1.30 0.31 2.60 -5.34%
DY 1.62 1.31 0.70 1.38 1.80 0.64 1.21 4.98%
P/NAPS 1.54 1.86 2.78 3.15 2.27 2.58 1.95 -3.85%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment